Theophylline in chronic asthma - Evidence for disease-modifying properties

Clinical and Experimental Allergy, Supplement

Volumn 26, Issue 2, 1996, Pages 22-27

  Chung, K F ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; THEOPHYLLINE;

ADULT; AGED; ASTHMA; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG THERAPY; ETIOLOGY; FEMALE; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ANIMALS; ASTHMA; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; THEOPHYLLINE;

EID: 0029990259     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Rall TW. The methylxanthines. In: Gilman A, Goodman LS, Rall TW, Murad F, eds. The Pharmacological Basis of Therapeutics. Macmillan Publishing, 1985:589-603.
2. Jenne JW, Wyze E, Rood FS, MacDonald FS. Pharmacokinetics of theophylline. Application to adjust of clinical dose of aminophylline. Clin Pharmacol Ther 1972; 13:349-60.
3. Hendeles L, Weinberger MM. Theophylline: A state-of-the-art review. Pharmacotherapy 1983; 3:2-44.
4. Mitenko PA, Ogilvie RI. Rational intravenous doses of theophylline. N Eng J Med 1973; 289:600-3.
5. Racineux JL, Troussier J, Turcant A. Comparison of bronchodilator effect of salbutamol and theophylline. Bull Eur Physiopathol Respir 1981; 17:799-806.
6. British Thoracic Society. Guidelines on the management of asthma. Thorax 1993; 48 (Suppl):S1-S24.
7. Sheffer AL. Interntional Consencus Report on diagnosis and management of asthma. Eur Resp J 1992; 5:601-41.
8. Kidney J, Dominguez M, Taylor PM et al. Immunomodulation by thophylline in asthma: demonstration by withdrawal therapy. Am J Respir Crit Care Med 1995; 15:1907-14.
9. Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
10. Chung KF. Inflammatory, mechanisms in asthma. In: Barnes PJ, ed. Royal Brompton Review Series Volume II. Oxford: Butterworth-Heinemann, 1993:32-56.
11. Robinson DS, Durham SR, Kay AB. Cytokines in asthma. Thorax 1993; 48:845-53.
12. Katsumata U, Miura M, Ichinose M et al. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 1990; 141:1158-61.
13. Chanez P, Yukawa T, Dent G et al. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with platelet-activating factor and pharbolester. Eur Respir J 1990; 3:1002-7.
14. Vachier I, Chanez P, Le Doucen C et al. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Resp J 1994; 7:1585-92.
15. Nielson CP, Crowley JJ, Cusak BJ, Vestal RE. Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation. J Allergy Clin Immunol 1986; 78:660-7.
16. Nielson CP, Vestal RE, Sturm RJ, Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol 1990; 86:801-8.
17. Schrier DJ, Imre RM. The effects of adenosine antagonism on human neutrophil function. J Immunol 1986; 137:3284-9.
18. Calhoun WJ, Stevens CA, Lambert SB. Modulation of Superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 1991; 117:514-22.
19. O'Neill SJ, Sitar DS, Klass DJ et al. The pulmonary disposition of theophylline and its influence on human alveolar macrophage bactericidal function. Am Rev Respir Dis 1986; 134:1225-8.
20. Ghezzi P, Dinarello CA. IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma. J Immunol 1988; 140:4238-44.
21. Spatafora M, Chiappara G, Merendino AM et al. Theophylline suppresses the release of tumour necrosis factor-a by blood monocytes and alveolar macrophages. Eur Resp J 1994; 7:223-8.
22. Endres S, Fuller HJ, Sinha B et al. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-a and interleukin-1B by human mononuclear cells. Immunology 1991; 72:56-60.
23. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J Immunol 1991; 146:2712-8.
24. Yukawa T, Kroegel C, Chanez P et al. Effect of theophylline and adenosine on eosinophil function. Am Rev Respir Dis 1989; 140:327-33.
25. Limatibul S, Shore A, Dosch HM, Gelfand EW. Theophylline modulation of E-rosette formation: an indicator of T-cell maturation. Clin Exp Immunol 1978; 33:503-13.
26. Bruserud O. The effect of theophylline on T-lymphocyte activation in vitro. Clin Immunol Immunopath 1984;32:111-8.
27. Chisari FU, Edington TS. Human T-lymphocyte E-rosette formation I. A process modulated by intracellular cAMP. J Exp Med 1974; 104-1122-7.
28. Mary D, Aussel C, Ferrua B, Fehlmann M. Regulation of interleukin-2 synthesis by cAMP in human T-cells. J Immunol 1987; 139: 1179-84.
29. Hancock WW, Pleau ME, Kobzik L. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptors on human mononuclear phagocytes by induction of prostaglandis. J Immunol 1988; 140:1-3025.
30. Parti R, Rfffaella Zocchi M, Ferrero E et al. In vivo effects of a single infusion of theophylline on human peripheral blood lymphocytes. Clin Exp Immunol 1984; 57:722-8.
31. Fink G, Mittelman M, Shohat B, Spitzer SA. Theophylline-induced alterations in cellular immunity in asthmatic patients. Clin Allergy 1987; 17:313-16.
32. Scordamalgia A, Ciprandi G, Ruffoni S et al. Theophylline and the immune response: in vitro and in vivo effects. Clin Immunol Immunopathol 1988; 48:238-46.
33. Shohat B, Volovitz B, Varsano I. Induction of suppressor T cells in asthmatic children by theophylline treatment. Clin Allergy 1983; 13:487-93.
34. Ward AJM, McKenniff M, Evans JM et al. Theophylline: an immunomodulatory role in asthma. Am Rev Resp Dis 1993; 147:518-23.
35. Sullivan P, Bekir S, Jaffar Z et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343:1006-8.
36. Andersson P, Brange C, Sonmark B et al. Anti-anaphylactic and anti-inflammatory effects of santhines in the lung. In: Andersson KE, Persson CGA, eds. Antiasthma Xanthines and Adenosine. Amsterdam: Exerpta Medica 1985:187-92.
37. Sanjar S, Aoki S, Kristersson A et al. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitised guinea-pigs: the effect of anti-asthma drugs. Br J Pharmacol 1990; 99:679-86.
38. Tarayre JP, Aliga M, Barbara M et al. Model of bronchial allergic inflammation in the Brown Norway rat. Pharmacological modulation. Int J Immunopharmacol 1993; 14:847-55.
39. Kips JC, Tavernier JH, Peleman RA et al. Effect of theophylline on endotoxin and tumor necrosis factor induced airway changes in an in-vivo animal model. Int Arch Allergy Appl Immunol 1992; 99:478-81.
40. Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992; 145:332-6.
41. Persson CGA, Ekman M, Erjefalt I. Vascular anti-permeability effect of b-receptor agonists and theophylline in the lung. Acta Pharmacol et Toxicol 1979; 44:216-20.
42. Boschetto P, Roberts NM, Rogers DF, Barnes PJ. The effect of antiasthma drugs on microvascular leakage in guinea-pig airways. Am Rev Respir Dis 1989; 139:416-21.
43. Martin GL, Atkins PC, Dunsky EH, Zweiman B. Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immuinol 1980; 66:204-12.
44. Pauwels R, van Renterghem D, van der Straeten M et al. The effect of theophylline and enprofylline on allergen-induce bronchoconstriction. J Allergy Clin Immunol 1985;76:583-90.
45. Mapp C, Boschetto P, Vecchio L et al. Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness to toluene diisocyanate in sensitised subjects. Am Rev Respir Dis 1987; 136:1403-7.
46. Crescioli S, Spinazzi A, Plebani M et al. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatics. Ann Allergy 1991; 66:245-51.
47. Crescioli S, de Marzo N, Boschetto P et al. Theophylline inhibits late asthmatic reactions induced to toluene diisocyanate in sensitised subjects. Eur J Pharmacol Environ Toxicol 1992; 228:45-50.
48. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic reactions. Am Rev Respir Dis 1987; 136:740-51.
49. Cockroft DW, Murdoch KY, Gore BP et al. Theophylline does not inhibit allergen-induced increased airway responsiveness to methacholine. J Allergy Clin Immunol 1989; 83:913-20.
50. Furukawa CT, Shapiro SG, Bierman CW. A double-blind study comparing the effectiveness of cromolyn sodium and sustained release theophylline in childhood asthma. Pediatrics 1984; 74:435-9.
51. Nassif EG, Weinberger M, Thompson R, Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 1981; 304:71-5.
52. Weinberger M. The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol 1984; 73:525-40.
53. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chorinic, mild to mederate severe asthma in children. Pediatrics 1993; 92:64-77.
54. Greening AP, Baillie E, Gribbin HR, Pride NB. Sustained-release oral aminophylline in patients with airflow obstruction. Thorax 1981; 36:303-7.
55. Brenner M, Berkowitz R, Marshall N, Strunk RC. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy 1988; 18:143-50.
56. Polson JB, Krzanowski JJ, Goldman AL, Szentivanyi A. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol 1978; 5:535-40.
57. Bachelet M, Vincent D, Havet N. Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma. J Allergy Clin Immunol 1991; 88:322-8.
58. Townley RG. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect. J Lab Clin Med 1993; 121:44-51.
59. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991; 46:512-23.